Consideration of substance use in compensation and pension examinations of veterans filing PTSD claims.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 30 11 2017
accepted: 04 01 2019
entrez: 7 2 2019
pubmed: 7 2 2019
medline: 14 11 2019
Statut: epublish

Résumé

Veterans filing claims that service-induced PTSD impairs them worry that claims examiners may attribute their difficulties to conditions other than PTSD, such as substance use. Substance use commonly co-occurs with PTSD and complicates establishing a PTSD diagnosis because symptoms may be explained by PTSD alone, PTSD-induced substance use, or by a substance use condition independent of PTSD. These alternative explanations of symptoms lead to different conclusions about whether a PTSD diagnosis can be made. How substance use impacts an examiner's diagnosis of PTSD in a Veteran's service-connection claim has not been previously studied. In this study, we tested the hypothesis that mention of risky substance use in the Compensation & Pension (C&P) examination would result in a lower likelihood of service-connection award, presumably because substance use reflected an alternative explanation for symptoms. Data were analyzed from 208 Veterans' C&P examinations, medical records, and confidentially-collected research assessments. In this sample, 165/208 (79%) Veterans' claims were approved for a mental health condition; 70/83 (84%) with risky substance use mentioned and 95/125 (76%) without risky use mentioned (p = .02). Contrary to the a priori hypothesis, Veterans with risky substance use were more likely to get a service-connection award, even after controlling for baseline PTSD severity and other potential confounds. They had almost twice the odds of receiving any mental health award and 2.4 times greater odds of receiving an award for PTSD specifically. These data contradict assertions of bias against Veterans with risky substance use when their claims are reviewed. The data are more consistent with substance use often being judged as a symptom of PTSD. The more liberal granting of awards is consistent with literature concerning comorbid PTSD and substance use, and with claims procedures that make it more likely that substance use will be attributed to trauma exposure than to other causes.

Identifiants

pubmed: 30726261
doi: 10.1371/journal.pone.0210938
pii: PONE-D-17-42219
pmc: PMC6364894
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0210938

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Addict Behav. 2014 Feb;39(2):445-8
pubmed: 24090622
Arch Gen Psychiatry. 1995 Dec;52(12):1048-60
pubmed: 7492257
J Trauma Stress. 2001 Apr;14(2):259-75
pubmed: 11469155
Arch Gen Psychiatry. 1998 Oct;55(10):913-7
pubmed: 9783562
J Subst Abuse Treat. 2005 Jul;29(1):29-37
pubmed: 15979529
Psychiatr Serv. 2001 Nov;52(11):1479-84
pubmed: 11684743
Med Care. 2005 Feb;43(2):112-21
pubmed: 15655424
J Stud Alcohol. 1992 Jul;53(4):357-63
pubmed: 1619930
Psychol Assess. 2017 Jun;29(6):710-719
pubmed: 28594214
Am J Psychiatry. 1985 Nov;142(11):1259-64
pubmed: 3904487
Biol Psychiatry. 1996 Sep 1;40(5):368-72
pubmed: 8874837
J Pers Assess. 1997 Apr;68(2):369-84
pubmed: 9107014
J Trauma Stress. 2012 Dec;25(6):607-15
pubmed: 23225029
J Clin Psychiatry. 2016 Apr;77(4):517-22
pubmed: 26797388
Contemp Clin Trials. 2005 Dec;26(6):626-36
pubmed: 16236558
J Trauma Stress. 2011 Oct;24(5):609-13
pubmed: 21913226
J Nerv Ment Dis. 2006 Sep;194(9):690-6
pubmed: 16971821
Addict Behav. 1995 Sep-Oct;20(5):643-55
pubmed: 8712061
Drug Alcohol Depend. 2011 Jul 1;116(1-3):93-101
pubmed: 21277712
Addict Behav. 2010 Jan;35(1):64-7
pubmed: 19729250
Am J Psychiatry. 1996 Mar;153(3):369-75
pubmed: 8610824
J Pers Assess. 1996 Dec;67(3):588-97
pubmed: 8991972
Addict Res Theory. 2015;23(2):148-155
pubmed: 27812315
Med Care. 2003 Apr;41(4):536-49
pubmed: 12665717
Addict Behav. 1998 Nov-Dec;23(6):797-812
pubmed: 9801717
Am J Psychiatry. 1992 May;149(5):664-70
pubmed: 1575258
Recent Dev Alcohol. 1988;6:49-68
pubmed: 3283864
Rehabil Psychol. 2011 Feb;56(1):26-31
pubmed: 21401283
Addict Behav. 2010 Sep;35(9):840-3
pubmed: 20471180
Psychiatr Serv. 2017 Apr 1;68(4):396-399
pubmed: 27629795
N Engl J Med. 2004 Jul 1;351(1):13-22
pubmed: 15229303
Brain Sci. 2017 Jan 05;7(1):
pubmed: 28067785
JAMA. 2008 Aug 13;300(6):663-75
pubmed: 18698065
Arch Gen Psychiatry. 2011 Oct;68(10):1072-80
pubmed: 21969464
Harv Rev Psychiatry. 1997 Jan-Feb;4(5):231-44
pubmed: 9385000
Science. 1991 Mar 29;251(5001):1580-6
pubmed: 2011738
Addict Behav. 2007 Aug;32(8):1719-27
pubmed: 17188816
Am J Addict. 1998 Spring;7(2):128-35
pubmed: 9598216
J Trauma Stress. 1995 Jan;8(1):75-90
pubmed: 7712061
Arch Phys Med Rehabil. 2009 Apr;90(4):652-6
pubmed: 19345782
Am J Psychiatry. 2001 Aug;158(8):1184-90
pubmed: 11481147
Mil Med. 2005 Oct;170(10):867-70
pubmed: 16435761

Auteurs

Rebecca L Jankowski (RL)

VA Central Western Massachusetts Healthcare System, Leeds, Massachusetts, United States of America.

Anne C Black (AC)

VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.
Yale University, New Haven, Connecticut, United States of America.

Christina M Lazar (CM)

VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.
Yale University, New Haven, Connecticut, United States of America.

Bradley R Brummett (BR)

VA Central Western Massachusetts Healthcare System, Leeds, Massachusetts, United States of America.

Marc I Rosen (MI)

VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.
Yale University, New Haven, Connecticut, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH